Our case study reveals CRISPR’s potential in gene editing progeria aging disease, giving children a normal lifespan through innovative gene therapy.
Our case study reveals CRISPR’s potential in gene editing progeria aging disease, giving children a normal lifespan through innovative gene therapy.